FORENDO PHARMA
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions and Fispemifene, a novel SERM, enabling medical companies to improve the treatment of male urological conditions and giving new opportunities to unmet needs in women's and men's health.
FORENDO PHARMA
Industry:
Health Care Medical Pharmaceutical
Founded:
2013-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Website Url:
http://www.forendo.com
Total Employee:
11+
Status:
Active
Contact:
(358) 403-1080
Total Funding:
25.2 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Facebook Sharer Twitter Tweet Button
Similar Organizations
Galmed Pharmaceuticals
Galmed develop innovative, proprietary drugs for the treatment of lipids and liver diseases.
Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Risto Lammintausta Co-Founder & CEO @ Forendo Pharma
Co-Founder & CEO
2013-06-01
Founder
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Forendo Pharma
M Ventures
M Ventures investment in Venture Round - Forendo Pharma
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Venture Round - Forendo Pharma
Novo Holdings
Novo Holdings investment in Venture Round - Forendo Pharma
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Venture Round - Forendo Pharma
Novo Holdings
Novo Holdings investment in Venture Round - Forendo Pharma
M Ventures
M Ventures investment in Venture Round - Forendo Pharma
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Forendo Pharma
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Venture Round - Forendo Pharma
Karolinska
Karolinska investment in Venture Round - Forendo Pharma
Official Site Inspections
http://www.forendo.com
- Host name: ec2-54-194-133-94.eu-west-1.compute.amazonaws.com
- IP address: 54.194.133.94
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Forendo Pharma"
Forendo Pharma - Crunchbase Company Profile & Funding
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. The company's drugs are competent in tissue-specific hormone …See details»
Organon Completes Acquisition of Forendo Pharma
Dec 13, 2021 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo …See details»
Organon to Acquire Forendo Pharma
Nov 11, 2021 Risto Lammintausta, CEO of Forendo, emphasized the importance of the transaction: “This is a great opportunity for Forendo to join forces with a larger organization …See details»
Organon to Acquire Forendo Pharma - ESG
Nov 11, 2021 Risto Lammintausta, CEO of Forendo, emphasized the importance of the transaction: “This is a great opportunity for Forendo to join forces with a larger organization …See details»
Organon R&D Finland - Craft
Nov 11, 2021 Organon R&D Finland (formerly Forendo Pharma) is a drug development company focusing on novel treatments in women's health. Its pipeline includes HSD17B1 …See details»
Forendo Pharma Ltd Overview | SignalHire Company Profile
Forendo Pharma Ltd is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of …See details»
Forendo Pharma - Company Profile - Tracxn
Jan 1, 2025 Forendo Pharma develops small molecule therapeutics for reproductive health. The company specializes in tissue-specific regulation of sex hormone effects and has two …See details»
Forendo Pharma - VentureRadar
Forendo Pharma is a drug development company based in Turku, Finland. Its core competence resides in organ specific hormone mechanisms, giving new opportunities to unmet needs in …See details»
Forendo Pharma - Funding, Financials, Valuation & Investors
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. Search Crunchbase. ... How much funding has this organization …See details»
Forendo Pharma - Contacts, Employees, Board Members
Organization. Forendo Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Forendo Pharma has 1 current employee …See details»
Organon to Acquire Forendo Pharma - Business Wire
Nov 11, 2021 Risto Lammintausta, CEO of Forendo, emphasized the importance of the transaction: “ This is a great opportunity for Forendo to join forces with a larger organization …See details»
Organon to Acquire Forendo Pharma - Nasdaq
Nov 11, 2021 Risto Lammintausta, CEO of Forendo, emphasized the importance of the transaction: “This is a great opportunity for Forendo to join forces with a larger organization …See details»
Organon Completes Acquisition of Forendo Pharma | ESG
Dec 13, 2021 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo …See details»
Organon to acquire drug development company Forendo Pharma
Nov 12, 2021 Forendo is entitled to receive up to $270m on meeting some development and regulatory milestones and commercial milestone payments of up to $600m. The lead drug of …See details»
Organon Completes the Acquisition of Forendo Pharma, a Biotech …
Dec 17, 2021 Women’s Health Pharma company and Merck spin-off Organon, has completed its recently announced acquisition of Forendo Pharma, a clinical-stage drug development …See details»
Organon Completes Acquisition of Forendo Pharma - Nasdaq
Dec 13, 2021 Organon, a global women’ s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company …See details»
Organon acquires Forendo Pharma - 2021-11-11 - Crunchbase
Nov 12, 2021 Organon acquires Forendo Pharma on 2021-11-11 for $945000000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Forendo Pharma acquired by …See details»
Organon Completes Acquisition of Forendo Pharma
Dec 14, 2021 Organon announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. …See details»
Organon to Acquire Forendo Pharma - Pipelinereview
Nov 12, 2021 Risto Lammintausta, CEO of Forendo, emphasized the importance of the transaction: “This is a great opportunity for Forendo to join forces with a larger organization …See details»
Organon to Snap up Forendo Pharma for $954M - Nasdaq
Nov 12, 2021 Forendo CEO Risto Lammintausta highlighted, “This is a great opportunity for Forendo to join forces with a larger organization capable of accelerating the development of …See details»